Research

Virginia Kaklamani, M.D., D.Sc., is a Professor of Medicine in the division of Hematology/Oncology at the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio. She is also the is the leader of the Breast Oncology Program at UT Health San Antonio’s Mays Cancer Center. Dr. Kaklamani is working to repurpose an approved drug called cyclosporin, a widely used immunosuppressant, which has been found to also killed a specific type of cancer cells. This collaborative discovery enabled Dr. Kaklamani to quickly prepare for clinical trials as it has already been approved by the Food and Drug Administration, that its results may bring hope to patients with inherited breast and ovarian cancer.

Bradley B. Brimhall, MD is a Professor of Pathology and Laboratory Medicine at the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio and the Director of Laboratory Medicine and Clinical Informatics/Healthcare Analytics at UT Health San Antonio. Dr. Brimhall and his collaborative teams of researchers are harnessing the power of artificial intelligence and predictive modeling to develop leading-edge diagnostics. By utilizing machine learning and artificial intelligence, physicians will be able to segment images, recognize features, calculate geometric parameters and hopefully make the images more usable and quantifiable for physicians to better diagnose and optimize patient treatments.